U.S. Cancer Contrast Media Market Size, Forecasts 2024-2032

U.S. Cancer Contrast Media Market Size – By Product Type (Gadolinium-based Contrast Media, Iodinated Contrast Media), Modality (Nuclear Imaging, CT, MRI, Mammography), Application (Breast Cancer, Bladder Cancer, Lung Cancer), End-use & Forecast, 2024 – 2032

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Market scope &amp; definitions

1.2&nbsp;&nbsp;&nbsp; Base estimates &amp; calculations

1.3&nbsp;&nbsp;&nbsp; Data collection

1.4&nbsp;&nbsp;&nbsp; Forecast parameters

1.5&nbsp;&nbsp;&nbsp; Data validation

1.6&nbsp;&nbsp;&nbsp; Data sources

1.6.1&nbsp;&nbsp;&nbsp; Primary

1.6.2&nbsp;&nbsp;&nbsp; Secondary

1.6.2.1&nbsp;&nbsp;&nbsp; Paid sources

1.6.2.2&nbsp;&nbsp;&nbsp; Public sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Industry 3600 synopsis

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp; Increasing number of clinical studies

3.2.1.2&nbsp;&nbsp;&nbsp; Rising prevalence of cancer cases

3.2.1.3&nbsp;&nbsp;&nbsp; Technological advancements in cancer contrast imaging

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp; Side effects and adverse reactions related to contrast agents

3.2.2.2&nbsp;&nbsp;&nbsp; Presence of alternative imaging options

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4&nbsp;&nbsp;&nbsp; Regulatory landscape

3.5&nbsp;&nbsp;&nbsp; Technological landscape

3.6&nbsp;&nbsp;&nbsp; Porter&#39;s analysis

3.6.1&nbsp;&nbsp;&nbsp; Supplier power

3.6.2&nbsp;&nbsp;&nbsp; Buyer power

3.6.3&nbsp;&nbsp;&nbsp; Threat of new entrants

3.6.4&nbsp;&nbsp;&nbsp; Threat of substitutes

3.6.5&nbsp;&nbsp;&nbsp; Industry rivalry

3.7&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2023

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company market share analysis

4.3&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.4&nbsp;&nbsp;&nbsp; Strategy outlook matrix

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Product Type, 2018 &ndash; 2032 ($ Mn)

5.1&nbsp;&nbsp;&nbsp; Key trends

5.2&nbsp;&nbsp;&nbsp; Gadolinium-based contrast media

5.3&nbsp;&nbsp;&nbsp; Iodinated contrast media

5.4&nbsp;&nbsp;&nbsp; Radioactive agents

5.5&nbsp;&nbsp;&nbsp; Other product types

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Modality, 2018 &ndash; 2032 ($ Mn)

6.1&nbsp;&nbsp;&nbsp; Key trends

6.2&nbsp;&nbsp;&nbsp; Nuclear imaging

6.3&nbsp;&nbsp;&nbsp; CT scan

6.4&nbsp;&nbsp;&nbsp; Mammography

6.5&nbsp;&nbsp;&nbsp; MRI scan

6.6&nbsp;&nbsp;&nbsp; Ultrasound

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Application, 2018 &ndash; 2032 ($ Mn)

7.1&nbsp;&nbsp;&nbsp; Key trends

7.2&nbsp;&nbsp;&nbsp; Breast cancer

7.3&nbsp;&nbsp;&nbsp; Bladder cancer

7.4&nbsp;&nbsp;&nbsp; Colorectal cancer

7.5&nbsp;&nbsp;&nbsp; Lung cancer

7.6&nbsp;&nbsp;&nbsp; Prostate cancer

7.7&nbsp;&nbsp;&nbsp; Other applications

Chapter 8&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By End-Use, 2018 &ndash; 2032 ($ Mn)

8.1&nbsp;&nbsp;&nbsp; Key trends

8.2&nbsp;&nbsp;&nbsp; Hospitals

8.3&nbsp;&nbsp;&nbsp; Specialty clinics

8.4&nbsp;&nbsp;&nbsp; Diagnostic centers

8.5&nbsp;&nbsp;&nbsp; Other end-users

Chapter 9&nbsp;&nbsp;&nbsp;Company Profiles

9.1&nbsp;&nbsp;&nbsp; Bayer AG

9.2&nbsp;&nbsp;&nbsp; Bracco Imaging S.p.A.

9.3&nbsp;&nbsp;&nbsp; GE Healthcare Technologies Inc

9.4&nbsp;&nbsp;&nbsp; Guerbet

9.5&nbsp;&nbsp;&nbsp; iMAX Diagnostic Imaging

9.6&nbsp;&nbsp;&nbsp; Lantheus Medical Imaging

9.7&nbsp;&nbsp;&nbsp; nanoPET Pharma GmbH

9.8&nbsp;&nbsp;&nbsp; Subtle Medical, Inc

9.9&nbsp;&nbsp;&nbsp; Telix Pharmaceuticals Limited

9.10&nbsp;&nbsp;&nbsp; Trivitron Healthcare 
&nbsp;

US Cancer Contrast Media Market

Get a free sample of this report